Michael Seth Altman - 30 Jun 2023 Form 4 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role
Director
Signature
/s/ Jason Cavalier, Attorney-in-Fact for Michael Seth Altman
Issuer symbol
LYRA
Transactions as of
30 Jun 2023
Transactions value $
$0
Form type
4
Filing time
05 Jul 2023, 21:49:08 UTC
Previous filing
20 Jun 2023
Next filing
11 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LYRA Stock Option Award $0 +20K $0.00 20K 30 Jun 2023 Common Stock 20K $4.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests and becomes exercisable on June 30, 2024, subject to the Non-Employee Director's continued service on the Board as a Non-Employee Director through such vesting date.